SIRT1 inhibition has also been proposed in the treatment of virus infections [71], whereas SIRT2 inhibitors might be useful for the treatment of cancer and neurodegenerative diseases [80,81,83]. This evidence concerns the gene SIRT1 and viral infectious disease.